Cecilia Vecoli

Dr. Cecilia Vecoli

Institute of Clinical Physiology-CNR, Pisa, Italy
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2008 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
DTDouglas D. Thomas
Douglas D. Thomas
LRLisa A. Ridnour
Lisa A. Ridnour
JIJeffrey S. Isenberg
Jeffrey S. Isenberg
WFWilmarie Flores-Santana
Wilmarie Flores-Santana
CSChristopher H. Switzer
Christopher H. Switzer
DWDavid Wink
David Wink

1 December 2007 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
DNDanilo Neglia
Danilo Neglia
ACAlberto De Caterina
Alberto De Caterina
PMPaolo Marraccini
Paolo Marraccini
ANAndrea Natali
Andrea Natali
MCMarco Ciardetti
Marco Ciardetti
FRFabio A. Recchia
Fabio A. Recchia
Under resting conditions, the failing heart shifts fuel use toward greater glucose and lower free fatty acid (FFA) oxidation. We hypothesized that chronic metabolic abnormalities in patients with dilated cardiomyopathy (DCM) are associated with the absence of the normal increase in myocardial glucose uptake and maintenance of cardiac mechanical efficiency in response to pacing stress. In 10 DCM patients and 6 control subjects, we measured coronary flow by intravascular ultrasonometry and sampled arterial and coronary sinus blood. Myocardial metabolism was determined at baseline, during atrial pacing at 130 beats/min, and at 15 min of recovery by infusion of [3H]oleate and [13C]lactate and measurement of transmyocardial arteriovenous differences of oxygen and metabolites. At baseline, DCM patients showed depressed coronary flow, reduced uptake and oxidation of FFA, and preferential utilization of carbohydrates. During pacing, glucose uptake increased by 106% in control subjects but did not change from baseline in DCM patients. Lactate release increased by 122% in DCM patients but not in control subjects. Cardiac mechanical efficiency in DCM patients was not different compared with control subjects at baseline but was 34% lower during stress. Fatty acid uptake and oxidation did not change with pacing in either group. Our results show that in DCM there is preferential utilization of carbohydrates, which is associated with reduced flow and oxygen consumption at rest and an impaired ability to increase glucose uptake during stress. These metabolic abnormalities might contribute to progressive cardiac deterioration and represent a target for therapeutic strategies aimed at modulating cardiac substrate utilization.

5 December 2008 in Circulation Research
Verified
Journal Article
Closed access
PDF file
GRGenaro A. Ramirez-Correa
Genaro A. Ramirez-Correa
WJWenhai Jin
Wenhai Jin
ZWZihao Wang
Zihao Wang
XZXin Zhong
Xin Zhong
WGWei Dong Gao
Wei Dong Gao
AMAnne M. Murphy
Anne M. Murphy
In addition to O -phosphorylation, O -linked modifications of serine and threonine by β- N -acetyl- d -glucosamine (GlcNAc) may regulate muscle contractile function. This study assessed the potential role of O -GlcNAcylation in cardiac muscle contractile activation. To identify specific sites of O -GlcNAcylation in cardiac myofilament proteins, a recently developed methodology based on GalNAz-biotin labeling followed by dithiothreitol replacement and light chromatography/tandem mass spectrometry site mapping was adopted. Thirty-two O -GlcNAcylated peptides from cardiac myofilaments were identified on cardiac myosin heavy chain, actin, myosin light chains, and troponin I. To assess the potential physiological role of the GlcNAc, force–[Ca 2+ ] relationships were studied in skinned rat trabeculae. Exposure to GlcNAc significantly decreased calcium sensitivity (pCa50), whereas maximal force ( F max ) and Hill coefficient ( n ) were not modified. Using a pan-specific O -GlcNAc antibody, it was determined that acute exposure of myofilaments to GlcNAc induced a significant increase in actin O -GlcNAcylation. This study provides the first identification of O -GlcNAcylation sites in cardiac myofilament proteins and demonstrates their potential role in regulating myocardial contractile function.

11 April 2013 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
IFIlenia Foffa
Ilenia Foffa
LALamia Ait-Ali
Lamia Ait-Ali
PPPaola Panesi
Paola Panesi
MMMassimiliano Mariani
Massimiliano Mariani
PFPierluigi Festa
Pierluigi Festa
Maria Grazia AndreassiMaria Grazia Andreassi
Maria Grazia Andreassi
Background: The purpose of our study was to investigate the potential contribution of germline mutations in NOTCH1, GATA5 and TGFBR1 and TGFBR2 genes in a cohort of Italian patients with familial Bicuspid Aortic Valve (BAV). Methods: All the coding exons including adjacent intronic as well as 5′ and 3′ untranslated (UTR) sequences of NOTCH1, GATA5, TGFBR1 and TGFBR2 genes were screened by direct gene sequencing in 11 index patients (8 males; age = 42 ± 19 years) with familial BAV defined as two or more affected members. Results: Two novel mutations, a missense and a nonsense mutation (Exon 5, p.P284L; Exon 26, p.Y1619X), were found in the NOTCH1 gene in two unrelated families. The mutations segregated with the disease in these families, and they were not found on 200 unrelated chromosomes from ethnically matched controls. No pathogenetic mutation was identified in GATA5, TGFBR1 and TGFBR2 genes. Conclusions: Two novel NOTCH1 mutations were identified in two Italian families with BAV, highlighting the role of a NOTCH1 signaling pathway in BAV and its aortic complications. These findings are of relevance for genetic counseling and clinical care of families presenting with BAV. Future studies are needed in order to unravel the still largely unknown genetics of BAV.

6 November 2014 in Current Genomics
Verified
Journal Article
Open access
PDF file
CVCecilia Vecoli
Cecilia Vecoli
SPSilvia Pulignani
Silvia Pulignani
IFIlenia Foffa
Ilenia Foffa
Maria Grazia AndreassiMaria Grazia Andreassi
Maria Grazia Andreassi
Congenital heart diseases (CHDs) are recognized as the most common type of birth malformations. Although recent advances in pre- and neonatal diagnosis as well as in surgical procedures have reduced the morbidity and mortality for many CHD, the etiology for CHD remains undefined. In non-syndromic and isolated (without a familial history or a Mendelian inheritance) forms of CHDs, a multifactorial pathogenesis with interplay between inherited and non-inherited causes is recognized. In this paper, we discuss the current knowledge of the potential molecular mechanisms, mediating abnormal cardiac development in non-syndromic and isolated CHD, including mutations in cardiac transcription factors, the role of somatic mutations and epigenetic alterations as well as the influence of gene-environment interactions. In the near future, the advent of high-throughput genomic technologies with the integration of system biology will expand our understanding of isolated, non-syndromic CHDs for their prevention, early diagnosis and therapy.

1 December 2007 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
ALAntonio L'ABbate
Antonio L'ABbate
DNDanilo Neglia
Danilo Neglia
CVCecilia Vecoli
Cecilia Vecoli
MNMichela Novelli
Michela Novelli
VOVirginia Ottaviano
Virginia Ottaviano
Nader G. AbrahamNader G. Abraham
Nader G. Abraham
Transient reduction in coronary perfusion pressure in the isolated mouse heart increases microvascular resistance (paradoxical vasoconstriction) by an endothelium-mediated mechanism. To assess the presence and extent of paradoxical vasoconstriction in hearts from normal and diabetic rats and to determine whether increased heme oxygenase (HO)-1 expression and HO activity, using cobalt protoporphyrin (CoPP), attenuates coronary microvascular response, male Wistar rats were rendered diabetic with nicotinamide/streptozotocin for 2 wk and either CoPP or vehicle was administered by intraperitoneal injection weekly for 3 wk (0.5 mg/100 g body wt). The isolated beating nonworking heart was submitted to transient low perfusion pressure (20 mmHg), and coronary resistance (CR) was measured. During low perfusion pressure, CR increased and was associated with increased lactate release. In diabetic rats, CR was higher, HO-1 expression and endothelial nitric oxide synthase were downregulated, and inducible nitric oxide synthase and O2− were upregulated. After 3 wk of CoPP treatment, HO activity was significantly increased in the heart. Upregulation of HO-1 expression and HO activity by CoPP resulted in the abolition of paradoxical vasoconstriction and a reduction in oxidative ischemic damage. In addition, there was a marked increase in serum adiponectin. Elevated HO-1 expression was associated with increased expression of cardiac endothelial nitric oxide synthase, B-cell leukemia/lymphoma extra long, and phospho activator protein kinase levels and decreased levels of inducible nitric oxide synthase and malondialdehyde. These results suggest a critical role for HO-1 in microvascular tone control and myocardial protection during ischemia in both normal and mildly diabetic rats through the modulation of constitutive and inducible nitric oxide synthase expression and activity, and an increase in serum adiponectin.